ADMA Biologics, Inc. (ADMA)
17.95
-0.12
(-0.66%)
USD |
NASDAQ |
Jan 09, 16:00
18.09
+0.14
(+0.78%)
After-Hours: 20:00
ADMA Biologics Research and Development Expense (Quarterly): 1.528M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 22.56M |
| Aldeyra Therapeutics, Inc. | 5.431M |
| Arcutis Biotherapeutics, Inc. | 19.60M |
| Marker Therapeutics, Inc. | 2.346M |
| CorMedix, Inc. | 5.098M |